Search Results 1531-1540 of 14895 for Hepatitis C

1. Cholangiocarcinoma (bile duct cancer) - Doctors and departments - Mayo Clinic

   Find a doctor whose last name begins with the letter C C ... C, Nonalcoholic fatty liver disease ... hepatitis, Hepatopulmonary syndrome, Viral hepatitis.

2. A Study Of TRK-950 In Patients With Advanced Solid Tumors - Mayo Clinic

   ... C). Unwillingness or inability to comply with procedures required in this protocol. Known active infection with HIV, hepatitis B, hepatitis C. Symptomatic ...

3. Erectile dysfunction - Doctors and departments - Mayo Clinic

   Horsley, M.D.. Internist. Phoenix, AZ. Areas of focus: LGBT health care, Sexual dysfunction, Hepatitis C, Hepatitis B, HIV/AIDS, Erectile dysfunction, Sexually ...

4. A Study Of Nivolumab And Multi-fraction Stereotactic Radiosurgery With Or Without Ipilimumab In Treating Participants With Recurrent Grade II-III Meningioma - Mayo Clinic

   However, patients with human immunodeficiency virus (HIV) on stable therapy with minimal viral loads and patients with hepatitis B and hepatitis C who have ...

5. A Clinical Study Of MK-1084 With Targeted Therapy And Chemotherapy In People With Colorectal Cancer (MK-1084-012/KANDLELIT-012) - Mayo Clinic

   * Participants with history of hepatitis C virus (HCV) infection are eligible if HCV viral load is undetectable. Exclusion Criteria: The main exclusion ...

6. And Compared With CIS And GEM Alone In HA-high Subjects With Previously Untreated, Unresectable, Locally Advanced, Or Metastatic Intrahepatic And Extrahepatic Cholangiocarcinoma And Gallbladder Adenocarcinoma - Mayo Clinic

   Active hepatitis B virus (HBV) infection, defined as having a positive hepatitis B surface antigen (HBsAg) test at screening. Active hepatitis C virus ...

7. A Trial Of The FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered As Maintenance Therapy Following Allogeneic Transplant For Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML) - Mayo Clinic

   Participant has active hepatitis C infection as determined by NAAT. NAAT must be performed if the participant has positive serology for hepatitis C.

8. Everolimus And Letrozole In Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, Or Primary Peritoneal Cavity Cancer - Mayo Clinic

   ... hepatitis B virus surface antigen [HBsAg], or quantifiable hepatitis C virus [HCV]-ribonucleic acid [RNA] in serum). Participating Mayo Clinic locations.

9. A Study Of R-ICE And Lenalidomide For Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Subjects with hepatitis C antibody will be eligible provided that they do not have elevated liver transaminases or other evidence of active hepatitis ...

10. Mesenchymal Stem Cell Therapy For Lung Rejection - Mayo Clinic

    Positive screening for HIV Hepatitis B and Hepatitis C. Evidence of liver dysfunction; Liver profile showing alkaline phosphatase higher than 345 u/L, total ...